IFNG and neoplasm: CXCL9 further promotes tumor infiltration of IFNγ‐expressing T cells that resultantly enhance CXCL9 expression within tumor microenvironments.36 Thus, targeting Shp2 in macrophages may create Th1‐dominant tumor microenvironments.